This study is looking at a new way to check surgical margins (the edges of removed tissue) for basal cell carcinoma (a common type of skin cancer). Researchers are using a device called two photon fluorescence microscopy (TPFM) to image the removed tissue right after surgery. The goal is to see how well TPFM can identify any remaining cancer cells compared to the standard method used in the lab. You might be able to join if you are having basal cell carcinoma removed without Mohs surgery at the study location and can understand the consent form. The study will be considered successful if the TPFM measurements of clear margins closely match the results from the standard lab tests. The current recruitment status is unclear.

Study design

This is an interventional study that plans to enroll 52 participants. It will compare a new imaging technique to standard lab tests.

What's involved

Your excised tissue will be imaged with two photon fluorescence microscopy before it goes to the lab for standard processing. All patients will receive standard care confirmation after the experimental imaging.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint is measured upon receipt of postoperative pathology slides, typically 2-4 weeks post surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.